SBX-2023

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameSBX-2023
Drug Alias NameSBX-2023
ClassificationNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesStramsen Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesStramsen Biotech Inc
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A